Human metapneumovirus M2-2 protein inhibits innate cellular signaling by targeting MAVS

Journal of Virology

Volumn 86, Issue 23, 2012, Pages 13049-13061

  Ren, Junping ^a   Wang, Qingrong ^a   Kolli, Deepthi ^a   Prusak, Deborah J ^a,b   Tseng, Chien Te K ^a   Chen, Zhijian J ^c   Li, Kui ^d   Wood, Thomas G ^a,b   Bao, Xiaoyong ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GUANINE NUCLEOTIDE BINDING PROTEIN; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 8; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN M2; PROTEIN M2 2; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENE REPLICATION; HUMAN METAPNEUMOVIRUS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; M2 2 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; REVERSE GENETICS; RNA SYNTHESIS; SITE DIRECTED MUTAGENESIS; STOP CODON; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS VIRULENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; DNA PRIMERS; HUMANS; IMMUNE EVASION; IMMUNOPRECIPITATION; METAPNEUMOVIRUS; PLASMIDS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VERO CELLS; VIRAL PROTEINS; VIRULENCE FACTORS;

ANIMALIA; HUMAN METAPNEUMOVIRUS;

EID: 84869223930     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01248-12     Document Type: Article

References (56)

1. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
2. Alff PJ, et al. 2006. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J. Virol. 80: 9676-9686.
3. Andrejeva J, et al. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFNbeta promoter. Proc. Natl. Acad. Sci. U. S. A. 101:17264-17269.
4. Bannister R, et al. 2010. Use of a highly sensitive strand-specific quantitative PCR to identify abortive replication in the mouse model of respiratory syncytial virus disease. Virol. J. 7:250. doi:10.1186/1743-422X-7-250.
5. Bao X, et al. 2008. Human metapneumovirus small hydrophobic protein inhibits NF-kappaB transcriptional activity. J. Virol. 82:8224-8229.
6. Bao X, et al. 2008. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog. 4:e1000077. doi:10.1371/ journal.ppat.1000077.
7. Bao X, et al. 2007. Airway epithelial cell response to human metapneumovirus infection. Virology 368:91-101.
8. Barnes B, Lubyova B, Pitha PM. 2002. On the role of IRF in host defense. J. Interferon Cytokine Res. 22:59-71.
9. Bermingham A, Collins PL. 1999. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc. Natl. Acad. Sci. U. S. A. 96: 11259-11264.
10. Biacchesi S, et al. 2005. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J. Virol. 79:12608-12613.
11. Biacchesi S, et al. 2004. Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. Virology 321:247-259.
12. Biacchesi S, et al. 2004. Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J. Virol. 78:12877-12887.
13. Buchholz UJ, et al. 2005. Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J. Virol. 79:6588-6597.
14. Buchholz UJ, Nagashima K, Murphy BR, Collins PL. 2006. Live vaccines for human metapneumovirus designed by reverse genetics. Expert Rev. Vaccines 5:695-706.
15. Casola A, Henderson A, Liu T, Garofalo RP, Brasier AR. 2002. Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:L1280- L1290.
16. De BP, Hoffman MA, Choudhary S, Huntley CC, Banerjee AK. 2000. Role of NH(2)- and COOH-terminal domains of the P protein of human parainfluenza virus type 3 in transcription and replication. J. Virol. 74: 5886-5895.
17. Englund JA, et al. 2006. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann. Intern. Med. 144:344-349.
18. Falsey AR, Erdman D, Anderson LJ, Walsh EE. 2003. Human metapneumovirus infections in young and elderly adults. J. Infect. Dis. 187: 785-790.
19. Ferguson MK, Botchan MR. 1996. Genetic analysis of the activation domain of bovine papillomavirus protein E2: its role in transcription and replication. J. Virol. 70:4193-4199.
20. Fontana JM, Bankamp B, Rota PA. 2008. Inhibition of interferon induction and signaling by paramyxoviruses. Immunol. Rev. 225:46-67.
21. Garofalo RP, et al. 1996. Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation. J. Virol. 70:8773-8781.
22. Gould CM, et al. 2010. ELM: the status of the 2010 eukaryotic linear motif resource. Nucleic Acids Res. 38:D167-D180.
23. Goutagny N, et al. 2010. Cell type-specific recognition of human metapneumoviruses (HMPVs) by retinoic acid-inducible gene I (RIG-I) and TLR7 and viral interference of RIG-I ligand recognition by HMPV-B1 phosphoprotein. J. Immunol. 184:1168-1179.
24. Graef KM, et al. 2010. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J. Virol. 84:8433-8445.
25. Guerrero-Plata A, et al. 2005. Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J. Virol. 79:10190-10199.
26. Guo Z, et al. 2007. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am. J. Respir. Cell Mol. Biol. 36:263-269.
27. Herfst S, et al. 2004. Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA. J. Virol. 78:8264-8270.
28. Jin H, et al. 2000. Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo. Virology 273:210-218.
29. Kato H, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105.
30. Kawai T, Akira S. 2007. Antiviral signaling through pattern recognition receptors. J. Biochem. 141:137-145.
31. Kawai T, Akira S. 2008. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 1143:1-20.
32. Kitagawa Y, et al. 2010. Human metapneumovirus M2-2 protein inhibits viral transcription and replication. Microbes Infect. 12:135-145.
33. Kolli D, et al. 2011. Human metapneumovirus glycoprotein G inhibits TLR4-dependent signaling in monocyte-derived dendritic cells. J. Immunol. 187:47-54.
34. Liao S, et al. 2008. Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling. J. Gen. Virol. 89:1978-1986.
35. Lin R, Heylbroeck C, Genin P, Pitha PM, Hiscott J. 1999. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol. Cell. Biol. 19:959-966.
36. Ling Z, Tran KC, Teng MN. 2009. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J. Virol. 83:3734-3742.
37. Opitz B, et al. 2007. IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell. Microbiol. 9:930-938.
38. Pham QN, et al. 2005. Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo. J. Virol. 79:15114-15122.
39. Ranganathan R, Ross EM. 1997. PDZ domain proteins: scaffolds for signaling complexes. Curr. Biol. 7:R770 -R773.
40. Ren J, et al. 2011. A novel mechanism for inhibition of IRF-3-dependent gene expression by human respiratory syncytial virus NS1 protein. J. Gen. Virol. 92:2153-2159.
41. Schickli JH, et al. 2008. Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters. Virol. J. 5:69. doi:10.1186/1743-422X-5-69.
42. Schreiber E, Matthias P, Muller MM, Schaffner W. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419. doi:10.1093/nar/ 17.15.6419.
43. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682.
44. Sun Q, et al. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24:633-642.
45. Sutherland KA, Collins PL, Peeples ME. 2001. Synergistic effects of gene-end signal mutations and the M2-1 protein on transcription termination by respiratory syncytial virus. Virology 288:295-307.
46. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655.
47. Teng MN, et al. 2000. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J. Virol. 74:9317-9321.
48. Tian B, et al. 2002. Identification of NF-kB dependent gene networks in respiratory syncytial virus-infected cells. J. Virol. 76:6800-6814.
49. van den Hoogen BG, Bestebroer TM, Osterhaus AD, Fouchier RA. 2002. Analysis of the genomic sequence of a human metapneumovirus. Virology 295:119-132.
50. van den Hoogen BG, et al. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7:719-724.
51. Varga ZT, et al. 2011. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog. 7:e1002067. doi:10.1371/journal.ppat.1002067.
52. Wang J, et al. 2006. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9. J. Biol. Chem. 281:37427-37434.
53. Wang X, et al. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 74:11566-11573.
54. Wen C, et al. 2012. Identification of tyrosine-9 of MAVS as critical target for inducible phosphorylation that determines activation. PLoS One 7:e41687. doi:10.1371/journal.pone.0041687.
55. Williams JV, et al. 2006. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J. Infect. Dis. 193:387-395.
56. Yoneyama M, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.